FM
Publications
172
Views
91,666
Downloads
10,195
Supervised works
0
Items per page
1 - 172 of 172
Title Published in Access level OA Policy Year Views Downloads
Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery diseaseInternational journal of molecular sciences
accessLevelPublic
2022 151 175
Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle CellsCells
accessLevelPublic
2022 165 165
NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosisInternational journal of molecular sciences
accessLevelPublic
2021 182 136
A genetic polymorphism in the pannexin1 gene predisposes for the development of endothelial dysfunction with increasing BMIBiomolecules
accessLevelPublic
2020 398 140
Cardiotrophin-1 Deficiency Abrogates Atherosclerosis ProgressionScientific Reports
accessLevelPublic
2020 177 157
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3Thrombosis and Haemostasis
accessLevelRestricted
2020 202 0
HDL protects against myocardial ischemia reperfusion injury via miR-34b and miR-337 expression which requires STAT3PLOS ONE
accessLevelPublic
2019 245 152
Anti-apolipoprotein A-1 autoantibodies are associated with immunodeficiency and systemic inflammation in HIV patientsJournal of Infection
accessLevelRestricted
2018 505 1
Serum cardiovascular risk biomarkers in pre-pubertal obese childrenEuropean Journal of Clinical Investigation
accessLevelPublic
2018 275 337
Anti-Apolipoprotein A-1 IgG Predict All-Cause Mortality and Are Associated with Fc Receptor-Like 3 PolymorphismsFrontiers in Immunology
accessLevelPublic
2017 426 196
Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General PopulationArteriosclerosis, Thrombosis, and Vascular Biology
accessLevelRestricted
2017 424 0
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary functionInternational Journal of Cardiology
accessLevelRestricted
2017 474 0
4D cardiac imaging at clinical 3.0T provides accurate assessment of murine myocardial function and viabilityMagnetic Resonance Imaging
accessLevelRestricted
2017 522 2
The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenationInternational journal of cardiology
accessLevelRestricted
2016 539 0
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophagesVascular pharmacology
2016 509 0
Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatmentsEuropean heart journal
accessLevelRestricted
2016 588 3
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injuryJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2016 543 1
Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus studyThrombosis and haemostasis
accessLevelRestricted
2016 515 7
Prognostic value of PCSK9 levels in patients with acute coronary syndromesEuropean heart journal
accessLevelRestricted
2016 587 2
Protective role of necrostatin-1 in acute myocardial infarctionEuropean journal of clinical investigation
accessLevelRestricted
2016 468 2
Role of Neutrophils in Atherogenesis: an UpdateEuropean journal of clinical investigation
accessLevelRestricted
2016 477 2
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesisThrombosis and haemostasis
accessLevelRestricted
2016 682 1
Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43Cardiovascular research
accessLevelRestricted
2016 636 6
Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomesEuropean journal of clinical investigation
accessLevelRestricted
2016 578 6
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosisThrombosis and haemostasis
accessLevelPublic
2016 695 537
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery StenosisMediators of Inflammation
accessLevelPublic
2016 447 175
Potential useful prognostic parameters after transcatheter aortic valve implantation: editorialEuropean journal of clinical investigation
accessLevelRestricted
2016 450 1
Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2Antioxidants & redox signaling
accessLevelRestricted
2015 559 0
Emerging pathophysiological relevance for neutrophils in acute coronary syndromesEuropean journal of clinical investigation
accessLevelRestricted
2015 423 0
The role of adipocytokines in atherogenesis and atheroprogressionCurrent drug targets
2015 489 0
Diagnostic and prognostic value of autoantibodies anti-apolipoprotein A-1 and anti-phosphorylcholine in acute non-ST elevation myocardial infarctionEuropean journal of clinical investigation
accessLevelRestricted
2015 588 3
Update on the role of angiotensin in the pathophysiology of coronary atherothrombosisEuropean journal of clinical investigation
accessLevelRestricted
2015 486 0
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy populationEuropean journal of clinical investigation
accessLevelRestricted
2015 624 0
Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injuryPloS one
accessLevelPublic
2015 598 228
Leptin/adiponectin ratio predicts post-stroke neurological outcomeEuropean journal of clinical investigation
accessLevelRestricted
2015 530 1
Inflammation in arterial diseasesIUBMB life
accessLevelRestricted
2015 450 0
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient miceVascular pharmacology
accessLevelRestricted
2015 512 1
Clinical relevance of adverse intracerebral artery remodeling in patients with HIVNeurology
accessLevelRestricted
2015 413 0
Serum osteopontin levels are upregulated and predict disability after an ischaemic strokeEuropean journal of clinical investigation
accessLevelRestricted
2015 585 0
Update on strategies limiting iatrogenic hypoglycemiaEndocrine connections
accessLevelPublic
2015 412 163
Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathwaysEuropean heart journal
accessLevelRestricted
2015 611 2
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte responseVascular pharmacology
accessLevelRestricted
2015 683 0
Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15Journal of diabetes research
accessLevelPrivate
2015 492 0
Editorial: update on inflammatory targets modulating atherogenesisCurrent drug targets
accessLevelRestricted
2015 435 0
Impact of propofol anaesthesia on cytokine expression profiles in the developing rat brain: a randomised placebo-controlled experimental in-vivo studyEuropean journal of anaesthesiology
accessLevelRestricted
2015 504 0
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathwaysVascular pharmacology
accessLevelRestricted
2015 789 4
Switch to etravirine for HIV-positive patients receiving statin treatment: a prospective studyEuropean journal of clinical investigation
accessLevelPrivate
2015 566 0
CD14 as a Mediator of the Mineralocorticoid Receptor-Dependent Anti-apolipoprotein A-1 IgG Chronotropic Effect on CardiomyocytesEndocrinology
accessLevelRestricted
2015 605 1
Impact of systemic inflammation and autoimmune diseases on apoA-I and HDL plasma levels and functionsHandbook of experimental pharmacology
accessLevelRestricted
2015 603 0
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathwaysThrombosis and haemostasis
accessLevelRestricted
2015 735 0
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injuryThe journal of sexual medicine
accessLevelRestricted
2015 548 0
Update on the role of neutrophils in atherosclerotic plaque vulnerabilityCurrent drug targets
2015 450 0
Evidence on the protective role of high-density lipoprotein (HDL) in HIV-infected individualsCurrent vascular pharmacology
2015 641 0
Editorial: is ischemic stroke an inflammatory disease?Current vascular pharmacology
accessLevelRestricted
2015 396 0
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic miceVascular pharmacology
accessLevelRestricted
2015 562 0
APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia CellsClinical cancer research
accessLevelRestricted
2015 465 0
Role of matrix metalloproteinases in animal models of ischemic strokeCurrent vascular pharmacology
2015 496 0
Treatment with apixaban in a patient with recent chronic subdural haematoma: a case reportSchweizerische medizinische Wochenschrift
accessLevelPublic
2015 478 194
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4Thrombosis and haemostasis
accessLevelRestricted
2015 584 5
Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucoseMediators of inflammation
accessLevelPublic
2014 469 154
Update on the efficacy of statin treatment in acute coronary syndromesEuropean journal of clinical investigation
accessLevelRestricted
2014 557 0
Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitisEuropean journal of clinical investigation
accessLevelRestricted
2014 612 0
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic miceThrombosis and haemostasis
accessLevelRestricted
2014 738 0
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activityThe Journal of biological chemistry
accessLevelPrivate
2014 522 0
Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetesMediators of inflammation
accessLevelPublic
2014 495 63
Potential pathophysiological role for the vitamin D deficiency in essential hypertensionWorld journal of cardiology
accessLevelRestricted
2014 549 0
Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patientsEuropean journal of internal medicine
accessLevelRestricted
2014 527 0
Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathwaysBritish journal of pharmacology
accessLevelRestricted
2014 506 1
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaquesThrombosis and haemostasis
accessLevelRestricted
2014 521 0
Reply to "precipitants of heart failure must be fully considered when predicting readmission"European journal of clinical investigation
2014 568 0
Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in miceJournal of cerebral blood flow and metabolism
accessLevelPublic
2014 727 325
Inferior vena cava parameters predict re-admission in ischaemic heart failureEuropean journal of clinical investigation
accessLevelRestricted
2014 560 0
Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosisThrombosis and haemostasis
accessLevelRestricted
2014 610 0
Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosisMediators of inflammation
accessLevelPublic
2014 774 361
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseasesCurrent medicinal chemistry
2014 725 0
Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunityWorld journal of cardiology
accessLevelPublic
2014 615 217
Advanced glycation end products play adverse proinflammatory activities in osteoporosisMediators of inflammation
accessLevelPublic
2014 499 543
Angiotensin II receptor antagonists in acute coronary syndromesEuropean journal of clinical investigation
accessLevelRestricted
2014 470 0
Immunological aspects of atherosclerosisSeminars in immunopathology
accessLevelRestricted
2014 584 0
Carotid atherosclerotic plaque stenosis: the stabilizing role of statinsEuropean journal of clinical investigation
accessLevelRestricted
2014 489 0
Analysis of the expression of nine secreted matrix metalloproteinases and their endogenous inhibitors in the brain of mice subjected to ischaemic strokeThrombosis and haemostasis
accessLevelRestricted
2014 604 0
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndromeThrombosis and haemostasis
accessLevelRestricted
2013 508 0
Pathophysiological role of neutrophils in acute myocardial infarctionThrombosis and haemostasis
accessLevelRestricted
2013 523 0
Improvement in coronary circulatory function in morbidly obese individuals after gastric bypass-induced weight loss: relation to alterations in endocannabinoids and adipocytokinesEuropean heart journal
accessLevelRestricted
2013 523 0
Update on the protective molecular pathways improving pancreatic beta-cell dysfunctionMediators of inflammation
accessLevelPublic
2013 646 218
Reply to "Management of left ventricular thrombosis in patients with apical aneurysm"Schweizerische medizinische Wochenschrift
accessLevelRestricted
2013 405 0
Glucagon-like peptide-1 triggers protective pathways in pancreatic beta-cells exposed to glycated serumMediators of inflammation
accessLevelRestricted
2013 499 0
Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarctionAntioxidants & redox signaling
accessLevelPublic
2013 714 754
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomyThrombosis and haemostasis
accessLevelRestricted
2013 664 1
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancerWorld journal of surgical oncology
accessLevelPublic
2013 431 215
Role of matrix metalloproteinase-8 in atherosclerosisMediators of inflammation
accessLevelPublic
2013 504 211
Update on the pathophysiological activities of the cardiac molecule cardiotrophin-1 in obesityMediators of inflammation
accessLevelPublic
2013 518 231
The role of the intraplaque vitamin d system in atherogenesisScientífica
accessLevelPublic
2013 393 252
Takotsubo cardiomyopathy and torsade de pointes in myasthenic crisis: be aware of QT prolongationThe American journal of emergency medicine
accessLevelRestricted
2013 476 0
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in miceThrombosis and haemostasis
accessLevelRestricted
2013 692 0
What happened to a thrombus during apical ballooning syndrome: a case reportSchweizerische medizinische Wochenschrift
accessLevelRestricted
2013 494 0
Pathophysiological role of the renin-angiotensin system on erectile dysfunctionEuropean journal of clinical investigation
accessLevelPublic
2013 489 431
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndromeMediators of inflammation
accessLevelPublic
2013 509 195
Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinomaWorld journal of gastroenterology
accessLevelRestricted
2013 549 0
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetesMediators of inflammation
accessLevelPublic
2013 484 402
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experienceCurrent drug targets
2013 577 0
Retinal pigment epithelial cells express a functional receptor for glucagon-like peptide-1 (GLP-1)Mediators of inflammation
accessLevelPublic
2013 514 245
Inflammation is a key pathophysiological feature of metabolic syndromeMediators of inflammation
accessLevelPublic
2013 487 184
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemiaThe journal of sexual medicine
accessLevelRestricted
2013 510 0
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseasesThrombosis and haemostasis
accessLevelRestricted
2013 464 0
Autophagy in blood cancers: biological role and therapeutic implicationsHaematologica
accessLevelRestricted
2013 474 0
Update on evidence for treatment with ranolazine in stable anginaSchweizerische medizinische Wochenschrift
accessLevelRestricted
2013 469 0
Chronic myeloid leukemia: reaching for the cureCurrent cancer drug targets
accessLevelRestricted
2013 318 0
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in miceJournal of cerebral blood flow and metabolism
accessLevelRestricted
2013 673 0
Role of the renin-angiotensin system on abdominal aortic aneurysmsEuropean journal of clinical investigation
accessLevelRestricted
2013 460 0
Nicotinamide phosphoribosyltransferase as a target in inflammation- related disordersCurrent topics in medicinal chemistry
2013 429 0
Treatment with CB2 agonist JWH-133 reduces histological features associated with erectile dysfunction in hypercholesterolemic miceClinical & developmental immunology
accessLevelRestricted
2013 516 0
Auto-antibodies as Emergent Prognostic Markers and Possible Mediators of Ischemic Cardiovascular DiseasesClinical reviews in allergy & immunology
accessLevelRestricted
2013 610 3
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injuryJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2013 596 0
The vulnerable coronary plaque: update on imaging technologiesThrombosis and haemostasis
accessLevelRestricted
2013 402 0
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic miceArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2013 454 1
Serum resistin and inflammatory and endothelial activation markers in obese adolescentsThe Journal of pediatrics
accessLevelRestricted
2012 580 0
Anti-apolipoprotein A-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individualsMediators of inflammation
accessLevelPublic
2012 591 246
Coronary Vasomotor Control in Obesity and Morbid ObesityJACC. Cardiovascular imaging
accessLevelPublic
2012 697 625
Editorial: update on inflammatory processes governing atherosclerotic plaque vulnerability and reperfusion injuryCurrent pharmaceutical biotechnology
accessLevelRestricted
2012 383 0
Statins in the treatment of acute ischemic strokeCurrent pharmaceutical biotechnology
accessLevelRestricted
2012 479 0
Role of renin-angiotensin system in inflammation, immunity and agingCurrent pharmaceutical design
2012 478 0
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic MyocardiumCurrent signal transduction therapy
accessLevelRestricted
2012 546 0
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injuryEuropean journal of clinical investigation
accessLevelRestricted
2012 597 0
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancerWorld journal of gastroenterology
accessLevelRestricted
2012 477 0
At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunctionTrends in pharmacological sciences
accessLevelRestricted
2012 439 0
Role of cytokines and chemokines in non-alcoholic fatty liver diseaseWorld journal of gastroenterology
accessLevelRestricted
2012 352 1
Inhibition of the renin-angiotensin-aldosterone system: how to obtain thisCurrent pharmaceutical design
accessLevelRestricted
2012 412 0
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in miceEuropean heart journal
accessLevelRestricted
2012 644 1
Update on the evidence of statin treatment to reduce plaque vulnerabilityDrug metabolism letters
accessLevelRestricted
2012 533 0
Statins and stent thrombosisSchweizerische medizinische Wochenschrift
accessLevelRestricted
2012 437 0
Update on the role of cannabinoid receptors after ischemic strokeMediators of inflammation
accessLevelRestricted
2012 473 1
Elevated E-selectin and diastolic blood pressure in diabetic childrenEuropean journal of clinical investigation
accessLevelRestricted
2012 602 0
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaquesEuropean heart journal
accessLevelRestricted
2012 664 0
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiologyExpert review of cardiovascular therapy
2012 547 0
The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: a potential target for treating thrombotic diseasesThrombosis and haemostasis
accessLevelRestricted
2012 406 0
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activationCirculation
accessLevelRestricted
2012 457 0
Molecular imaging of matrix metalloproteinases in atherosclerotic plaquesThrombosis and haemostasis
accessLevelRestricted
2012 449 0
Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerabilityThrombosis and haemostasis
accessLevelRestricted
2012 740 0
Inflammatory cardiovascular risk biomarkers: update on novelties and limitationsMediators of inflammation
accessLevelRestricted
2012 484 0
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerabilityEuropean heart journal
accessLevelRestricted
2011 634 2
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndromeAmerican journal of physiology: endocrinology and metabolism
accessLevelRestricted
2011 618 0
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesityEuropean heart journal
accessLevelRestricted
2011 624 0
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signallingEuropean journal of clinical investigation
accessLevelRestricted
2010 532 0
Novel treatment strategy with direct renin inhibition against heart failurePanminerva Medica
2010 447 0
New evidence for nicotinic acid treatment to reduce atherosclerosisExpert review of cardiovascular therapy
2010 976 0
Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS)Sleep & breathing
accessLevelPublic
2010 560 345
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritisArthritis and rheumatism
accessLevelRestricted
2010 810 3
Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in miceArteriosclerosis, thrombosis, and vascular biology
accessLevelRestricted
2010 606 0
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic strokeStroke
accessLevelRestricted
2010 614 0
Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcificationCritical pathways in cardiology
2010 706 0
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusionJournal of Molecular and Cellular Cardiology
accessLevelRestricted
2009 725 0
Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndromeDiabetes, obesity & metabolism
accessLevelRestricted
2009 541 0
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosisRheumatology
accessLevelRestricted
2009 596 0
Ezetimibe/simvastatinExpert opinion on drug safety
accessLevelRestricted
2009 493 0
Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular riskPharmacological Reports
2009 466 0
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAIDS
accessLevelRestricted
2009 618 0
Chlorhexidine prevents hypochlorous acid-induced inactivation of alpha1-antitrypsinClinical and experimental pharmacology & physiology
accessLevelRestricted
2009 649 0
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesMediators of inflammation
accessLevelRestricted
2009 561 0
Atherosclerosis is an inflammatory diseaseSeminars in immunopathology
accessLevelPublic
2009 807 149
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytesRheumatology
accessLevelRestricted
2009 607 0
Update on statin-mediated anti-inflammatory activities in atherosclerosisSeminars in immunopathology
accessLevelPublic
2009 477 335
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosisAtherosclerosis
accessLevelRestricted
2009 565 0
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injuryThrombosis and haemostasis
2009 526 0
Statins, ACE inhibitors and ARBs in cardiovascular diseaseBaillière's best practice & research. Clinical endocrinology & metabolism
accessLevelRestricted
2009 560 0
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathwaysJournal of Biomedicine and Biotechnology
accessLevelRestricted
2009 487 0
Cannabinoid receptors in acute and chronic complications of atherosclerosisBritish journal of pharmacology
accessLevelRestricted
2008 583 0
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instabilityMediators of inflammation
accessLevelPublic
2008 553 480
Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathwaysCellular signalling
accessLevelRestricted
2008 656 0
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytesJournal of leukocyte biology
accessLevelRestricted
2008 596 0
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factorClinical interventions in aging
accessLevelPublic
2008 555 194
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathwaysAmerican journal of physiology. Heart and circulatory physiology
accessLevelRestricted
2008 584 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack